Skip Navigation Links

Bookmark and Share
Dialysis stocks surge after California rejected a limit on dialysis clinic revenues in the midterm elections (DVA, ARA, FMS)

DVA Nov9

  • Dialysis stocks are up Wednesday following the midterm election. 
  • The three big dialysis companies all received a bump. DaVita HealthCare is up 14%, American Renal Associates is up 4%, and Fresenius Medical is up 9%. 
  • Healthy kidneys help the body filter out impurities from the blood, and dialysis helps replace that function for patients whose kidneys aren't working properly.
  • The uptick in stocks in the industry is due to voter rejection of Proposition 8 in California. 
  • The ballot measure would have limited a dialysis clinic's revenue to 115% of the average cost of dialysis treatment in the state, according to analysts at Leerink. 
  • If Proposition 8 had passed, DaVita, one of the largest providers of dialysis, would have lost $450 million a year, California Healthline reported.

SEE ALSO: The 2018 midterms will have a big impact on healthcare, from Medicaid to abortion — here are the results

SEE ALSO: MORGAN STANLEY: Here are the 10 healthcare companies that are most likely to get acquired in the next 12 months

Join the conversation about this story »

NOW WATCH: Why you shouldn't be afraid to fly, according to a pilot with over 20 years of experience

Full "The Business Insider: The Money Game" article

Disclaimer | Terms Of Use And Privacy Statement

© Metals News. All rights reserved.